<xref rid="bib100" ref-type="bibr">Tyner et al., 2002</xref>). These data suggest that duplication of tumor suppressors can contribute to augmented cancer resistance, if the duplication includes sufficient regulatory architecture to direct spatially and temporally appropriate gene expression. Thus, it is interesting that duplication of genes that regulate TP53 function, such as 
 